Protagenic Therapeutics, Inc.\new (PTIX) Capital expenditures 2023–2026
Protagenic Therapeutics, Inc.\new (PTIX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$3,297FY2026 · since FY2023: $1,805 → $3,297
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3,297 | — |
| FY2024 | $149,775 | +8197.8% |
| FY2023 | $1,805 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice